GENPHARMA exchange filings, corporate actions and results
2 Sep 2026
⚑ Filing
Genpharmasec Ltd - 531592 - Intimation Of Book Closure For The Purpose Of AGMBSE filing · raw filing ↗
2 Sep 2026
⚑ Filing
Genpharmasec Ltd - 531592 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE filing · raw filing ↗
2 Sep 2026
⚑ Filing
Genpharmasec Ltd - 531592 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Wednesday, 02Nd September, 2026.BSE filing · raw filing ↗
2 Sep 2026
⚑ Filing
Genpharmasec Ltd - 531592 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
31 Aug 2026
⚑ Filing
Genpharmasec Ltd - 531592 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
28 Aug 2026
⚑ Filing
Genpharmasec Ltd - 531592 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, 02Nd September, 2026.BSE filing · raw filing ↗
13 Aug 2026
⚑ Filing
Genpharmasec Ltd - 531592 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE filing · raw filing ↗
13 Aug 2026
⚑ Filing
Genpharmasec Ltd - 531592 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
11 Aug 2026
⚑ Filing
Genpharmasec Ltd - 531592 - Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th June, 2026.BSE filing · raw filing ↗
11 Aug 2026
⚑ Result
Q1 FY27 results filed — revenue ₹50 Cr (+272.4% YoY), PAT ₹-0 Cr (−114.3% YoY)BSE filing · raw filing ↗
11 Aug 2026
⚑ Filing
Genpharmasec Ltd - 531592 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Tuesday, 11Th August, 2026.BSE filing · raw filing ↗
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
